Supply a non-prescription medicine
Information on how to supply a non-prescription medicine.
Last updated
Latest alerts
-
Pharmaceutical companies Novo Nordisk and Eli Lilly are discontinuing some of their insulin products.
-
The company which has supplied the CellAED devices, RRR Manufacturing Pty Ltd, has gone into liquidation. The liquidators for RRR Manufacturing, are conducting a Critical Recall for all lots of the CellAED device.
-
Supply constraints will apply to Creon 25,000 unit and 35,000 unit capsules until 30 June 2026.
Latest articles
-
Product Information safety updates - December 2025
Information for health professionals about medicines with safety related updates to their Product Information. -
Report issues with medicines and medical devices to help make them safer
Have you experienced an issue with a medicine or medical device?
Every report is important. Reports help us monitor the safety of medicines, vaccines and medical devices. -
GLP-1 RAs: warnings aligned over potential risk of suicidal thoughts or behaviours
Product warnings across the GLP-1 RA class of medicines have been aligned to ensure consistent information regarding the potential risk of suicidal thoughts or behaviours.
Latest publications
-
Communique from the 11th meeting of the Women's Health Products Working Group, 30 October 2025
-
Advisory Committee on Vaccines meeting statement 54
-
Medical device reforms: Consumer Working Group meeting statement, Meeting 17, 22 August 2025
Resources
-
This form is for sponsors to report Significant Safety Issues (SSIs) and Urgent Safety Measures (USMs) to the TGA.
-
Templates to help you with your communications under the Procedure for Recalls, Product Alerts and Product Corrections (PRAC).
Latest consultations
-
Survey on digital mental health tools.
-
This consultation paper seeks feedback on proposals identified for mitigating risks and leveraging opportunities associated with the use of AI models.
-
Have your say about proposed changes to address 3 medicine safety matters needing action, before we review labelling rules more broadly.